Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,558
Closed -$151K 995
2019
Q1
$151K Buy
11,558
+1,252
+12% +$21.9K ﹤0.01% 1064
2018
Q4
$155K Buy
10,306
+709
+7% +$18.3K ﹤0.01% 1011
2018
Q3
$377K Sell
9,597
-110
-1% -$4.96K 0.01% 819
2018
Q2
$477K Buy
9,707
+905
+10% +$51.3K 0.01% 717
2018
Q1
$526K Buy
8,802
+1,370
+18% +$91.4K 0.01% 662
2017
Q4
$585K Buy
7,432
+146
+2% +$11.8K 0.01% 618
2017
Q3
$611K Sell
7,286
-838
-10% -$59.4K 0.01% 619
2017
Q2
$531K Sell
8,124
-2,501
-24% -$170K 0.01% 608
2017
Q1
$772K Sell
10,625
-1,743
-14% -$115K 0.02% 500
2016
Q4
$722K Buy
+12,368
New +$653K 0.02% 554

Other funds holding ADNT

D.A. Davidson & Co's ADNT Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Adient (ADNT) in Q2 2019, closing a stake of 11,558 shares — an estimated $151K sold.

D.A. Davidson & Co first reported a position in ADNT in Q4 2016 and held it in 10 quarters. The position peaked at $772K in Q1 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 11,558 Adient shares in Q2 2019, an estimated $151K.
  • D.A. Davidson & Co first reported a position in Adient in Q4 2016 and held it in 10 quarters.
  • D.A. Davidson & Co's Adient position peaked at $772K in Q1 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.